Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 380 of 6351
-
Could a drug clear Alzheimer's plaques in people with down syndrome?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if donanemab can reduce levels of amyloid in the brain, and if donanemab is safe and well-tolerated in participants with Down syndrome. The main questions it aims to answer are: Does donanemab reduce amyloid in the brain? Is donanemab …
Phase 4 • Sponsor: Michael Rafii, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug could get heart surgery patients home days earlier
Disease control Not yet recruitingEA-230 is a new therapy that may help people recover faster and have fewer problems after bypass surgery. In an earlier clinical trial, participants who received EA-230 during Coronary Artery Bypass surgery stayed in the Intensive Care Unit (ICU) and the hospital for a shorter ti…
Phase 3 • Sponsor: EBI Anti Sepsis BV • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New drug cocktail aims to clear stubborn hand and foot pustules
Disease control Not yet recruitingPalmoplantar pustulosis (PPP) is a rare, chronic inflammatory skin disease primarily affecting the palms and soles. Currently, no treatment is specifically approved for PPP globally. This study aims to evaluate the efficacy and safety of tofacitinib combined with imatinib in pati…
Phase 3 • Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New hope for Hard-to-Treat prostate cancer: drug combo trial launches
Disease control Not yet recruitingThe purpose of this study is to find out whether mevrometostat in combination with enzalutamide delays cancer progression in people with metastatic castration-resistant prostate cancer (mCRPC) who have previously received enzalutamide, darolutamide, or apalutamide in the metastat…
Phase 2 • Sponsor: Prostate Cancer Clinical Trials Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New scoring tool aims to reverse type 2 diabetes with personalized plans
Disease control By invitation onlyThis study tests a new tool called the Snouda Metabolic Score (SMS) that helps doctors identify the specific metabolic problems driving Type 2 Diabetes in each individual patient. Instead of treating all diabetic patients the same way, the SMS classifies patients into one of seve…
Sponsor: Salah Snouda • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Zapping pancreatic tumors without surgery: a safer approach?
Disease control Not yet recruitingThis clinical trial tests the safety and feasibility of endoscopic ultrasound-guided pulsed electric field ablation for the treatment of pancreatic neoplasms. Pancreatic cancer is a fatal disease that is difficult to diagnose at an early stage. The approach for pancreatic neoplas…
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Pre-Surgery cocktail aims to boost liver cancer outcomes
Disease control Not yet recruitingThis is a prospective, single-arm clinical study designed to evaluate the efficacy and safety of an initial combination treatment strategy followed by surgery in patients with cancer. Eligible participants will receive combination therapy prior to surgical intervention. Patients …
Phase 2 • Sponsor: Affiliated Hospital of Guangdong Medical University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Single-Dose gene therapy aims to reprogram immune cells against tough leukemia
Disease control Not yet recruitingRelapsed or refractory acute leukemia (R/R AL) is a life-threatening blood cancer with poor outcomes and limited treatment options. PID23 Injection is an innovative in vivo CAR-T therapy that delivers a viral vector encoding three targets (CD19, BCMA, and CD70) directly into pati…
Early phase 1 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could unclogging brain arteries prevent strokes?
Disease control Not yet recruitingComparison of the efficacy and safety of endovascular treatment versus medical treatment in patients with chronic intracranial artery occlusion.
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Sound waves aimed at the brain could quiet tics without surgery
Symptom relief Not yet recruitingThis is a phase 1 clinical trial investigating the use of low-energy Transcranial Ultrasound Stimulation (TUS) to treat Tourette Syndrome (TS). Objectives and Background. TS is a neurodevelopmental condition marked by motor and vocal tics that often resist standard pharmacologic…
Phase 1 • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Can a targeted pill boost Chemo's power against a rare blood cancer?
Disease control Not yet recruitingThis is a single-arm, multicenter, Phase Ib/IIa study designed to explore the efficacy and safety of SHR2554 in combination with liposomal mitoxantrone for the treatment of patients with treatment-naive peripheral T-cell lymphoma (PTCL). The study is divided into a Phase Ib safet…
Phase 1/2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a heart drug tame rheumatoid arthritis?
Disease control Not yet recruitingThe aim of this clinical trial is to determine whether nicorandil works in minimizing disease severity in patients with rheumatoid arthritis. The study will also assess the safety and tolerability of nicorandil. The main questions it aims to answer are: * Could nicorandil improv…
Phase 2/3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can an experimental pill boost chemotherapy's power against stubborn uterine cancer?
Disease control Not yet recruitingThe purpose of this study is to evaluate whether treatment with the investigational drug OK-1 in combination with paclitaxel can reduce tumor burden in patients with advanced or recurrent endometrial cancer (A/R-EC).
Phase 2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
A dual sleep disorder: can one pill boost CPAP success?
Disease control Not yet recruitingCOMISA, the combination of obstructive sleep apnea (OSA) and insomnia, is a frequent and burdensome condition. Many patients with OSA experience clinically significant insomnia symptoms, and a substantial proportion of individuals with chronic insomnia also meet criteria for OSA.…
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a Dual-Action antibody outsmart advanced solid tumors?
Disease control Not yet recruitingThis study is an open-label, multicenter, dose-escalation and dose-expansion, non-randomized phase I clinical study evaluating the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SI-B036 bispecific antibody injection in patients with locally adva…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a targeted antibody calm severe eczema?
Disease control Not yet recruitingThis first-in-human study evaluates BYN-001, a humanized IgG1 monoclonal antibody targeting interleukin-25 (IL-25), a cytokine implicated in atopic dermatitis. Parts A and B are randomized, double-blind, placebo-controlled single and multiple ascending dose cohorts in healthy adu…
Phase 1 • Sponsor: Bionyra Pharma • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Blood and gut clues may flag pancreatic cancer risk early
Knowledge-focused Not yet recruitingThe goal of this observational study is to learn more about pancreatic cancer risk in people with chronic pancreatitis. Researchers will study blood markers and gut microorganisms, which are bacteria and other microbes living in the intestine. Researchers will compare healthy pa…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Sound therapy may retrain the ears of adults with autism to handle loud noises
Symptom relief Recruiting nowThe main goal of this clinical trial is to evaluate the effectiveness, benefits, and post-treatment persistence of an intervention for loudness hyperacusis in adults with autism spectrum disorder (ASD). The main questions it aims to answer are: * Does the intervention increase l…
Sponsor: University of Central Florida • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Team-Based care may cut hospital readmissions for a common heart failure
Disease control Not yet recruitingHeart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure cases and is associated with frequent hospitalizations, poor quality of life, and limited effective treatment options. Fragmented, single-discipline care often fails to add…
Sponsor: Chimei Medical Center • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a new scoring system and surgery boost pregnancy chances?
Disease control Recruiting nowThis clinical study aims to develop a comprehensive system to evaluate tubal function and to optimize individualized treatment strategies for patients with tubal factor infertility (caused by hydrosalpinx, obstruction, or adhesions). It will also assess whether integrating novel …
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC